Published in:
Open Access
01-12-2019 | Dyspnea | Letter
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate
Authors:
Andrea Cortegiani, Claudia Crimi, Alberto Noto, Yigal Helviz, Antonino Giarratano, Cesare Gregoretti, Sharon Einav
Published in:
Critical Care
|
Issue 1/2019
Login to get access
Excerpt
Systematic reviews comparing the effect of high-flow nasal treatment (HFNT) to conventional oxygen therapy (COT) or noninvasive ventilation (NIV) have focused on major clinical outcomes (i.e., endotracheal intubation, mortality) [
1‐
3]. None have explored weaker outcomes that may nonetheless be important from the patient’s perspective, yet physiopathological mechanisms suggest that the HFNT may provide some advantage in this regard [
4,
5]. We therefore systematically reviewed all randomized (RCTs) and crossover trials enrolling patients either post-extubation or during acute respiratory failure (ARF), comparing HFNT to COT or NIV and reporting data about dyspnea, comfort, and respiratory rate (RR) (PROSPERO CRD42019119536). …